Endovascular Engineering (E2)

Endovascular Engineering, Inc. ("E2"), is a mission driven, venture-backed company focusing on the development and deployment of groundbreaking clot removal technologies that target venous thromboembolism.

http://www.endovascularengineering.com

11-50 employees

Growth Trajectory

Endovascular Engineering's growth hinges on the successful completion of clinical trials and subsequent FDA approval of the Hēlo™ PE Thrombectomy System. With Series B funding secured, the company is focused on advancing clinical research, developing its technology, and potentially expanding its application to other thrombotic conditions beyond pulmonary embolism. Commercialization of their product represents a significant expansion opportunity.

Technical Challenges

Ensuring safety and efficacy of the Hēlo™ system in clinical trials.

Improving navigation in complex anatomies.

Reducing hemodynamic impact during thrombectomy procedures.

Optimizing clot engagement and removal techniques.

Tech Stack

Catheter-based thrombectomy technology

Team Size

Key Risks

Failure to obtain FDA approval for the Hēlo™ PE Thrombectomy System.

Competition from existing and emerging thrombectomy devices in the market.

Potential setbacks or negative outcomes in clinical trials impacting the Hēlo™ system's viability.

Challenges in scaling production and distribution upon commercialization.

Dependence on key partnerships with medical professionals and institutions.

Opportunities

Successful commercialization of the Hēlo™ PE Thrombectomy System, addressing a significant market need in pulmonary embolism treatment.

Expansion of the Hēlo™ system's application to treat other thrombotic conditions, broadening its market reach.

Strategic partnerships with hospitals and research institutions to drive adoption and innovation.

Further development of clot removal technologies, enhancing the system's efficacy and safety.

Leveraging clinical trial data to demonstrate superior outcomes and gain a competitive advantage.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats

Access Database

Updated every 5 minutes